Description: Teaching session on the working Medicare contracts: background on the origin of Medicare risk contracts, feasibility of an HMO or competitive medical plan entering the Medicare risk market, and outline of the HCFA adjusted community rate filing process.

Description: At this presentation from Session 72D of the SOA 1996 Colorado Springs Meeting, the panelists debate legislative changes to the Medicare program. Included is an overview of the changes in the 1995 legislation, expected savings in the Federal budget, a debate as to the realism of these expected savings, reaction of enrollees, and a discussion of anticipated effects on the private sector of the healthcare system. From the Record of the Society of Actuaries, Vol. 22, No. 2.

Description: An article recapping the SOA's participation in the NAIC Summer 2023 meeting.

Description: This article is focused on sustainability concerns in the ACA individual markets and what we can learn from core actuarial principles as discussed in ASOPs.

Description: The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The launch of Amjevita kicks off the process of changing the specialty drug marketplace in the United States. The expectation of the full impact of this big event is very hopeful, but there is still uncertainty several months after its beginning. Humira is the highest-selling drug in the world and has been since 2013 (Figure 1)—except for when COVID-19 projects temporarily surpassed it. The world is eagerly awaiting the launch of multiple biosimilar drugs to compete with Humira and hopefully bring more competitive pricing to the benefit of payers and patients everywhere.

Description: Prescribers, payers, and patients must put a higher priority on the comparative cost-effectiveness of competing pharmaceutical products if society is ever going to achieve rational and affordable drug use for all. From Prescription Drugs Monograph, M-HB04-1.

Description: Presented at October 2000 Annual Meeting. Discusses prescription cost trends, factors behind the trends, and cost management strategies for both the commercial and Medicare markets.

Description: This session discusses the merits of the Small Business Health Fairness Act [an amendment to ERSIA] and the implications of associations sponsoring health plans for small employer groups. From the Record of the Society of Actuaries, Volume 30, No. 1, Session 35

Description: Corin Chapman explores the many perspectives to consider when determining appropriate insurance regulation.

Description: Report on the activities of the Academy’s health practice council and its work groups.